Brief: Rani Therapeutics Enters Into $45 Mln Loan Agreement To Support Ranipill Platform Advancement
08/08/2022 13:31
Aug 8 (Reuters) - Rani Therapeutics Holdings Inc RANI.O :
* RANI THERAPEUTICS ENTERS INTO $45 MILLION LOAN AGREEMENT TO SUPPORT
ONGOING
RANIPILL® PLATFORM ADVANCEMENT AND CLINICAL PIPELINE DEVELOPMENT
Source text for Eikon: ID:nGNX5NC6YZ
Further company coverage: RANI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition